Skip to main content

The Business of Selling Hope

This is the third post to be loosely inspired by our recent trip to the Coalition for Compassionate Care of California (see here and here for the first two).

At the meeting, someone stood up and talked about how some hospitals will pander to patients who are intent on finding a cure, saying they are in the business of selling hope.  One could argue they are in the business of selling fear, but it seems they are two sides to a coin.

Let's take, just for example, the Cancer Treatment Centers of America.  I know nothing about this company, really, other than their advertising.  But here are some examples of their advertising:




Palliative care is not one of the 21 services listed on the Cancer Treatment Centers of America Treatments page.  Thanks to some further digging by Eric Widera, try sticking "advance care planning," or "advance directive," or "POLST" into their search box.  Nada, nothing, zilch.

And hospice?  Here is what they say about hospice:
Hospice is not a treatment option for cancer, but rather a means to improve the quality of life of cancer patients, and patients with terminal illnesses.
Hospice is not a treatment option for cancer?  For most advanced cancers, treatment is directed at palliating the symptoms and possibly prolonging life by small amounts of time.  Hospice certainly is a cancer treatment that accomplishes the former, and maybe the latter.

So here is the question - are companies such as this meeting consumer demand, or creating markets for themselves?  It's probably some of both - with both patients and physicians conspiring together in reinforcing fantasies of hope.  And it may be very profitable for companies like the Cancer Treatment Centers of America to meet and amplify consumer demand.

This reminds me of the recent study that showed patients with incurable cancer who thought chemotherapy would cure them rated their doctor less favorably than patients who believed chemotherapy might cure them.

So sure, it may make patients more satisfied in the short term.  We can sell this type of hope.  Maybe it's even easier, in the short term.  But at what cost?  Will patients and families look back and say "thank you" when their hopes are not fulfilled?  Or will it end in the ICU...

James Tulsky wrote a paper called, "Hope and Hubris" in the Journal of Palliative Medicine a decade ago.  In it, he expounds on Webster's two interpretations of hope: the first based on trust; the second on "desire accompanied by expectation of or belief in fulfillment."  The second type of hope requires that expectations be fulfilled, and is unlikely to be met by offering a cure to patients with incurable conditions.

However, even for patients who have a faith-based belief in cure despite the communication of realistic prognostic information, we can build and support hope, in the first sense, by building trust.  As he says in the conclusion of the article:
The physician who spends time with the patient, is honest but compassionate, and expresses empathy offers a hopeful presence even in the face of bad news.
Now that's the type of hope companies should be selling.

by: Alex Smith

Comments

Marian Grant, NP said…
These latest posts have been terrific. I can't tell you what a public service they perform. Please keep up this great work!
Lovely post Alex. By way of my childhood friend Lance - who passed away in 2010 after a 4 year struggle with pancreatic cancer - I can offer some color on the CTC's of America experience in selecting patients, and the search for 'hope' around the time of diagnosis. It was long ago, but I remember clearly the desperate hunt for alternatives to, of all places, Memorial Sloan Kettering (!). There was a physician in Mexico who promised a therapeutic agent which was 'highly effective in metastatic pancreatic cancer,' and he would send by mail for a fee. (I talked them out of that one!) Then there was the discussion around the CTC's of America. Their intake person spoke with Lance's wife, were eager to have them visit Dallas (?, maybe Phoenix?), but when the finances of the family were found to be as bleak as they were, the interest waned. Apparently the entry point to their services is an initial payment, after which some services are covered by insurance, but not all - especially travel. That's where the conversations ended. But the sell to the family was decidedly holistic, that much I remember.

In the end, MSD did right by my friend, but I have to admit their palliative chops were lacking in the end. The PC fellow was wonderful, but had no backing from the interventional and oncology teams, and she confessed as much to me on one of my multiple trips to/from NYC from SF in the final months.

Even in my current world - post-acute and long-term care - I often face pushback from operators and other physicians about the financial viability of the PC services that we are developing. So no surprise that pall/hospice care is left out of those most concerned with billable services.

Keep it up!

www.snfdocs.com
Hope & patience is most important factor in business
santa said…
Generally, it is believed that the cancer arises, or a pre existing cancer is encouraged, during the process of repairing the trauma, rather than the cancer being caused directly by the trauma. However, repeated injuries to the same tissues might promote excessive cell proliferation, which could then increase the odds of a cancerous mutation. There is no evidence that inflammation itself causes cancer. Thanks.
Regards,
creative bioscience green coffee

Popular posts from this blog

Practical Advice for the End of Life: A Podcast with BJ Miller

This week we talk with BJ Miller, hospice and palliative care physician, public speaker, and now author with Shoshana Berger of the book "A Beginner's Guide to the End."

As we note on the podcast, BJ is about as close as we get to a celebrity in Hospice and Palliative Care.  His TED Talk "What Really Matters at the End of Life" has been viewed more than 9 million times.  As we discuss on the Podcast, this has changed BJ's life, and he spends most of his working time engaged in public speaking, being the public "face" of the hospice and palliative care movement.

The book he and Berger wrote is filled to the brim with practical advice.  I mean, nuts and bolts practical advice.  Things like:
How to clean out not only your emotional house but your physical house (turns out there are services for that!)Posting about your illness on social media (should you post to Facebook)What is the difference between a funeral home and mortuaryCan I afford to die?  …

Caring, and the Family Caregivers We Don’t See

Over lunch at a restaurant in Manhattan, my father and I talked about long-term care insurance and the emergence of senior centers and nursing homes across the U.S. that offer a variety of ethnic cuisines and cultural events, catering not only to a growing population of adults over 65, but also, to an increasingly diverse population of adults who call the U.S. their home. This conversation was different from many similar ones before it – we weren’t talking about my research; we were talking about our own lives.
My parents immigrated to the U.S. in the late ‘70s and early ‘80s, following their parents’ advice on professional opportunities that seemed unimaginable in India at the time. Although they considered moving back soon after to care for their aging parents and to raise children, they ultimately decided to stay in the U.S. As I chronicled earlier, my paternal grandparents lived with us until I completed middle school, at which point they returned to India and lived with my mater…

Top 25 Studies in Hospice and Palliative Care (#HPMtop25)

by: Kara Bishoff (@kara_bischoff )

Back in 2015 we wrote a post asking for input on what articles should belong on a list of the top 25 articles in hospice and palliative care.   We decided to focus on hospice palliative care studies and trials - as opposed to review articles, consensus statements and opinion pieces.

Here’s what we came up with. It was hard to pick just 25! We highly prioritized clinical utility and tried to achieve diversity & balance. Many others are worthy of inclusion. Take a look and let us know if you have suggested changes for next year.

Module 1: Symptom Management
Randomized, Double-Blind, Placebo-Controlled Trial of Oral Docusate in the Management of Constipation in Hospice Patients. Tarumi Y et al. JPSM, 2013.Once-Daily Opioids for Chronic Dyspnea: A Dose Increment and Pharmacovigilance Study. Currow DC et al. JPSM, 2011.Effect of palliative oxygen versus room air in relief of breathlessness in patients with refractory dyspnoea: a double-blind, randomise…